Mark McClure

机构：University of Cambridge, Molecular Immunity Unit · ORCID：0000-0002-0398-9817

发表论文 26 篇 · 总被引 550 次 · h-index 12

代表论文

• B cell therapy in ANCA-associated vasculitis: current and emerging treatment options (2018 · Nature Reviews Rheumatology · 被引 114)
• Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease (2021 · Frontiers in Immunology · 被引 105)
• Evaluation of PR3-ANCA Status After Rituximab for ANCA-Associated Vasculitis (2019 · JCR Journal of Clinical Rheumatology · 被引 68)
• Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction models (2020 · Lara D. Veeken · 被引 40)
• Increasing incidence and improved survival in ANCA-associated vasculitis—a Danish nationwide study (2020 · Nephrology Dialysis Transplantation · 被引 39)
• Alemtuzumab for refractory primary systemic vasculitis—a randomised controlled dose ranging clinical trial of efficacy and safety (ALEVIATE) (2022 · Arthritis Research & Therapy · 被引 30)